Resources for Health Professionals
ASCIA resources for health professionals include Guidelines, Position Papers/Statements, Action Plans, Treatment Plans, Management Plans, Checklists and e-training courses.
Quick links for this page
COVID-19 | Allergic Rhinitis | Anaphylaxis | Drug (Medication) Allergy | Food Allergy | Immunodeficiency | Immunisation | Allergen Immunotherapy | Allergy Prevention and Infant Feeding | Insect Allergy | Latex Allergy | Skin | Tests | External Documents
COVID-19
- COVID-19 Vaccination Guidelines for Clinical Immunology/Allergy Specialists Updated September 2021
- Allergy, Immunodeficiency, Autoimmunity and COVID-19 Vaccination - Position Statement for health professionals Updated September 2021
- Allergy and COVID-19 Vaccination - Guide for health professionals Updated September 2021
- Immunodeficiency, Autoimmunity and COVID-19 Vaccination - Guide for health professionals Updated September 2021
Allergen Immunotherapy
- ASCIA Allergen Immunotherapy e-training for health professionals Updated May 2022
- ASCIA Guide - Venom Immunotherapy, References and Consent Form
- ASCIA Guide - Aeroallergen Immunotherapy, References, Allergen Selection Guide and Consent Form
- ASCIA Treatment Plan – Subcutaneous Immunotherapy (SCIT) Updated May 2021
- ASCIA Treatment Plan - Sublingual Immunotherapy (SLIT) New June 2021
- ASCIA Venom and Aeroallergen Immunotherapy templates (available to Members only)
Allergic Rhinitis
- ASCIA Allergic Rhinitis e-training for health professionals Updated March 2022
- ASCIA Allergic Rhinitis e-training for pharmacists Updated March 2022
- ASCIA Clinical Update - Allergic Rhinitis Currently being updated
- ASCIA Treatment Plan - Allergic Rhinitis
- Australian Airborne Pollen and Spore Monitoring Network Interim Standard and Protocols
- ASCIA Position Paper - Chronic Rhinosinusitis with Nasal Polyps New November 2021
- References - Chronic Rhinosinusitis with Nasal Polyps A-L New November 2021
- References - Chronic Rhinosinusitis with Nasal Polyps M-Z New November 2021
- References - Allergic Rhinitis New November 2021
Allergy Prevention and Infant Feeding
- ASCIA Allergy Prevention e-training for health professionals
- Overview - Infant feeding and allergy prevention
- ASCIA Position Statement - Packaged Foods for Infants that Contain Most of the Common Food Allergens New April 2021
- ASCIA Clinical Update Infant Feeding and Allergy Prevention
- ASCIA Guidelines - Infant feeding and allergy prevention
- ASCIA Stepwise management plan for eczema
- ASCIA Information on how to introduce solid foods to babies for allergy prevention
- ASCIA Guide for introduction of peanut to infants with severe eczema and/or food allergy
- References - Allergy Prevention
Anaphylaxis
- ASCIA Anaphylaxis e-training for health professionals Updated September 2021
- ASCIA Anaphylaxis refresher e-training for health professionals New February 2022
- ASCIA Anaphylaxis e-training for pharmacists Updated September 2021
- ASCIA Anaphylaxis refresher e-training for pharmacists New February 2022
- ASCIA Guidelines - Acute Management of Anaphylaxis Updated July 2021
- ASCIA Guidelines - Acute Management of Anaphylaxis in Pregnancy
- ASCIA Guidelines - Adrenaline (Epinephrine) Injector Prescription Updated March 2022
- ASCIA Guidelines Summary - Adrenaline (Epinephrine) Injector Prescription Updated March 2022
- ASCIA Guidelines - Prevention of anaphylaxis in schools, pre-schools and childcare
- ASCIA Anaphylaxis Resources Overview
- ASCIA Checklists - Anaphylaxis
- ASCIA Event record for allergic reactions
- ASCIA Checklist - Transitioning patients from paediatric to adult services
- ASCIA Checklist - Travel for people with allergy, asthma and anaphylaxis
- References - Anaphylaxis New June 2021
Drug (Medication) Allergy
- ASCIA Penicillin Allergy etraining for health professionals
- Drug (Medication) Allergy Hub
- ASCIA Consent Form - Antibiotic Allergy Challenges New March 2022
- ASCIA Action Plan for Drug (Medication) Allergy Updated June 2021
- ASCIA Record for Drug (Medication) Allergy Updated June 2021
- ASCIA Drug (Medication) Allergy Terms New August 2020
- ASCIA Consensus Statement - Penicillin Allergy Updated August 2020
- ASCIA Consensus Statement - Cephalosporin Allergy New July 2021 (available to Members only)
- ASCIA Drug allergy pre-clinic information template (available to Members only)
- ASCIA Clinical Update - Antibiotic Allergy
- References - Drug Cephalosporin Allergy
- References - Drug Penicillin Allergy
Food Allergy
- ASCIA Food Allergy e-training for health professionals Updated November 2021
- ASCIA Food Allergy e-training for pharmacists Updated November 2021
- ASCIA Position Paper - Food Allergen Challenges New March 2022
- ASCIA Consent Form - Food Allergen Challenges New March 2022
- ASCIA Position Paper - Oral Immunotherapy (OIT) for Food Allergy New April 2021
- ASCIA Guide - Milk Substitutes in Cow’s Milk (Dairy) Allergy Updated March 2022
- ASCIA Dietary Guides for Food Allergy
- ASCIA Information HP - Lupin Allergy
- ASCIA Food Allergen Challenge Protocols (available to Members only)
- References - Oral Immunotherapy (OIT) for Food Allergy
- References - Food Allergy Updated March 2022
- References - Food Allergen Challenges New March 2022
Immunodeficiency
- Primary Immunodeficiencies (PID) e-training for health professionals
- Immunoglobulin Replacement Therapy (IRT) e-training for health professionals New March 2022
- Hereditary Angioedema (HAE) e-training for health professionals In development
- ASCIA Immunodeficiency Strategy for Australia and New Zealand
- Immunodeficiency Overview
- ASCIA Position Statement - COVID-19 Prophylaxis in People with Immune Deficiencies New May 2022
- ASCIA Position Statement - Immunoglobulin Replacement Therapy (IRT) in Primary Immunodeficiency (PID) New September 2021
- ASCIA Webinar - HAE
- ASCIA Position Paper and Management Plan - Hereditary Angioedema (HAE)
- ASCIA Clinical Update - Primary Immunodeficiencies (PID)
- ASCIA Position Statement - Subcutaneous Immunoglobulin (SCIg)
- ASCIA Guide – Setting up a Subcutaneous Immunoglobulin (SCIg) program in a hospital
- ASCIA Guidelines for Diagnosis and Management of Severe Combined Immunodeficiency (SCID) in Australia and New Zealand: A TAPID Consensus Guideline
- ASCIA Guidelines - Standardised IVIg Infusion Rates for IRT
- ASCIA SCIg Treatment Plan
- ASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy)
- ASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy
- ASCIA SCIg Competency Training Checklists New May 2022
- ASCIA ID Register How to access information (available to Members Only)
- References - Immunodeficiency
- References - Hereditary Angioedema (HAE)
Immunisation
- ASCIA Guidelines - vaccination of the egg allergic individual
- ASCIA COVID-19 vaccine information New March 2021
Insect Allergy
- ASCIA Guide - Venom Immunotherapy, References and Consent Form
- ASCIA Venom and Aeroallergen Immunotherapy templates (available to Members only)
- ASCIA Position Statement - Jack Jumper Ant Venom Immunotherapy
- ASCIA Information for HP - Jack Jumper Ant Allergy - a uniquely Australian problem
- ASCIA Treatment Plan – Subcutaneous Immunotherapy (SCIT) Updated May 2021
- Information about Venom Immunotherapy availability
Latex Allergy
Skin
- ASCIA Paediatric atopic dermatitis (eczema) e-training for health professionals
- ASCIA Action Plan for Eczema Updated March 2022
- ASCIA Stepwise Management Plan for Eczema Updated March 2022
- ASCIA Position Paper Atopic Dermatitis (Eczema) In development
- ASCIA Position Paper - Chronic Spontaneous Urticaria (CSU)
- References - Chronic Spontaneous Urticaria (CSU)
- References - Atopic Dermatitis In development
Tests
- Laboratory Investigation of Allergic Diseases New December 2020
- ASCIA Position Paper - Evidence-Based Versus Non Evidence-Based Allergy Tests and Treatments New March 2021
- ASCIA Skin Prick Testing (SPT) Guide for Health Professionals
- ASCIA Food Allergen Challenge Protocols (available to Members only)
- References - Evidence-Based Versus Non Evidence-Based Allergy Tests and Treatments New March 2021
External Documents
-
RCPA - Pathology Tests - this list is searchable and provides basic information on a wide range of pathology tests across all disciplines.
- Australian Airborne Pollen and Spore Monitoring Network Interim Standard and Protocols
- Australian & New Zealand Anaesthetic Allergy Group (ANZAAG) - anaphylaxis management guidelines
- Australian Prescriber Anaphylaxis Wall Chart
- Australian Academy of Science - The science of immunisation
- APIIEG Consensus Recommendations for the Use of Immunoglobulin Replacement Therapy in Immune Deficiency
- Guidelines for the Use of Infant Formulas to Treat Cows Milk Protein Allergy: an Australian Consensus Panel Opinion
- European Academy of Allergology and Clinical Immunology (EAACI) Testing for IgG4 against Foods is Not Recommended as a Diagnostic Tool
For information about how ASCIA information is developed go to: www.allergy.org.au/about-ascia/website-information
Content updated May 2022